Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGEN

Agenus (AGEN)

Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AGEN
DateTimeSourceHeadlineSymbolCompany
06/30/20228:30AMGlobeNewswire Inc.Agenus to Participate at William Blair’s Biotech Focus ConferenceNASDAQ:AGENAgenus Inc
06/29/20227:00AMGlobeNewswire Inc.Agenus Shows Unprecedented Activity for Botensilimab/Balstilimab Combination in Microsatellite Stable Colorectal Cancer at ESMO World GI CongressNASDAQ:AGENAgenus Inc
06/21/20228:30AMGlobeNewswire Inc.Agenus to Host Investor Webcast to Review Late-Breaking Botensilimab and Balstilimab Data Presented at ESMO World GI CongressNASDAQ:AGENAgenus Inc
06/14/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
06/10/202211:15AMTipRanksB.Riley Financial Thinks Agenus’ Stock is Going to RecoverNASDAQ:AGENAgenus Inc
06/10/20228:00AMGlobeNewswire Inc.GSK’s RSV vaccine candidate for older adults, containing Agenus’ QS-21 STIMULON™ as part of GSK’s AS01 adjuvant, reports positive pivotal data supporting initiation of global regulatory submissionsNASDAQ:AGENAgenus Inc
06/09/20224:06PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AGENAgenus Inc
05/31/20228:30AMGlobeNewswire Inc.Agenus Advances Portfolio with 6 Clinical CollaborationsNASDAQ:AGENAgenus Inc
05/25/20228:30AMGlobeNewswire Inc.Agenus Announces Virtual Annual Shareholders MeetingNASDAQ:AGENAgenus Inc
05/25/20228:30AMGlobeNewswire Inc.Agenus to Participate at Jefferies Healthcare ConferenceNASDAQ:AGENAgenus Inc
05/24/20228:30AMGlobeNewswire Inc.Agenus Announces Late-Breaking Oral Presentation at ESMO-GI and Strategies to Advance BotensilimabNASDAQ:AGENAgenus Inc
05/10/20228:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
05/10/20228:00AMGlobeNewswire Inc.Agenus Corporate Update and First Quarter 2022 Financial ReportNASDAQ:AGENAgenus Inc
04/26/20228:30AMGlobeNewswire Inc.Agenus to Provide Corporate Update and First Quarter 2022 Financial ReportNASDAQ:AGENAgenus Inc
04/13/20227:45AMTipRanksB.Riley Financial Thinks Agenus’ Stock is Going to RecoverNASDAQ:AGENAgenus Inc
04/08/20224:35PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AGENAgenus Inc
04/08/20221:00PMGlobeNewswire Inc.Agenus Presents Data on AGEN1571 (anti-ILT2) at AACR and Announces IND ClearanceNASDAQ:AGENAgenus Inc
04/05/20226:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
04/05/20226:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
04/05/20226:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
04/05/20226:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
04/05/20228:30AMGlobeNewswire Inc.Agenus’ CD137 Agonist (AGEN2373) Advances in the Clinic, Triggering Milestone Payment from GileadNASDAQ:AGENAgenus Inc
03/07/20227:00AMGlobeNewswire Inc.Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™NASDAQ:AGENAgenus Inc
03/01/20228:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
03/01/20228:00AMGlobeNewswire Inc.Agenus Corporate Update and Fourth Quarter & Full Year 2021 Financial ReportNASDAQ:AGENAgenus Inc
03/01/20227:37AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:AGENAgenus Inc
02/15/20228:30AMGlobeNewswire Inc.Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial ReportNASDAQ:AGENAgenus Inc
02/11/20224:10PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AGENAgenus Inc
02/11/20224:01PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AGENAgenus Inc
02/10/20224:52PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AGENAgenus Inc
 Showing the most relevant articles for your search:NASDAQ:AGEN